Loading Ticker...

Archive for the 'Pharma' Category

Page 2 of 3

Piramal Health To Buy US-based “Decision Resources” for Rs 3,400 Crores

Piramal Healthcare Logo

Piramal Health is planning to acquire US-based Decision Resources which they think would be the last sector they would invest in. The group would be buying the US-based company for Rs 3,400 crore which is about $635 million. The group will now be entering into the $5.7 billion healthcare information management business according to Mr Ajay Piramal. Their company has become quite successful today due to the investments […]


Continue Reading...

Lupin Posts A Whopping Rs. 7,000 Crore Revenue

Lupin Pharma Logo

Being in the league of big pharma is definitely not an easy achievement for any drugmaker company. Among the companies that are in the league today is the Lupin Drugmaker with its revenue over Rs 7,000 crore. This company had started low. In fact they only have a Rs 1,200 crore revenue about nine years […]


Continue Reading...

GSK To Acquire Human Genome Sciences For Rs. 1.39 Lakh Crores?

GSK Logo Glaxo SmithKline

After its takeover was rejected last month by the U.S. biotech group’s board, the GlaxoSmithKline will take its $2.6 billion bid for Human Genome Sciences direct to stakeholders. According to Hodson Stonex, currently the sixth largest investor in Human Genome, GSK made a good decision. But, still they will be facing payments for this. The […]


Continue Reading...

Intas Pharma raises Rs 300 cr from ChrysCapital

Intas Pharma Logo

An investment into Intas Pharma will be done by a major private equity ChrysCapital. This investment will surely be an advantage for Intas Pharma, but it will delay their filing for an initial public offering. According to their Vice Chairman and managing director Mr Binish Chudgar, The funds for their company will surely stimulate more […]


Continue Reading...

Biocon Announces Q4 Figures – Rs. 97.8 Crore Profits

Biocon Logo

Biocon pharmaceuticals, one of India’s pharmaceutical major has reported 3% less profits at Rs.97.8 crore for Q4 of FY 2012 which ended on March 31st; main reason being zero licensing income during this quarter. Company’s revenues though showed a positive trend with an increase by 25% in the quarter to Rs.611.5 crore from Rs.487.9 crore […]


Continue Reading...

Rs 1,000 Crore Chemical Facility Being Setup At Dahej By BASF India

BASF Logo

A good news for people living at Dahej in Gujarat since a chemical facility is about to be set up in the mentioned place. This facility will house about 250 people at full capacity, primarily in operations. It will be starting its production in the year 2014. This is something that people in the place […]


Continue Reading...

Advent International To Invest Rs. 523 Crore In CARE Hospitals

CARE Hospitals Logo

It is definitely good news that there are companies like Advent International that is set to invest in CARE Hospitals. A statement from the mentioned company said that the purpose of the investment is to help CARE Hospitals improve their healthcare services and also to provide a good chance for growth and development. This will […]


Continue Reading...

Biocon And Pfizer Cancel Rs.1350 Crore Insulin Deal

Pfizer Logo

World’s largest drug producer company Pfizer called off the deal of selling $350 million (Approx Rs. 1350 Crore) insulin to Indian Biotech Company, Biocon’s insulin products globally. In a statement from the company, Pfizer declared that they are going to launch their own insulin drug, while Biocon demanded it to be launched in an alliance. […]


Continue Reading...